Novel Induction to Buprenorphine/Naloxone

PHASE4TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 6, 2023

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions

Opioid Use DisorderOpioid UseOpioid AbuseOpioid MisuseOpioid Dependence

Interventions

DRUG

buprenorphine/naloxone

Buprenorphine/naloxone will be used to begin each patient's treatment for opioid use disorder.

Trial Locations (1)

Bicycle Health, Boston